Milei's government managed to approve the patent treaty and deepens the relationship with the United States

Milei's government managed to approve the patent treaty and deepens the relationship with the United States

The Senate approved the accession to the PCT by 47 votes to 22 in a significant step in Milei and Trump's trade agenda

Share:

The Government of Javier Milei achieved a new legislative victory this Thursday: the Senate approved Argentina's adherence to the Patent Cooperation Treaty (PCT) by 47 votes in favor and 22 against. The final sanction allowed progress on an initiative promoted by the Executive Power and linked to the trade cooperation agenda that the President maintains with the administration of Donald Trump.

The approval represents a step forward in one of the chapters of the relationship with the United States. The trade and investment agreement signed on February 5, 2026, included Argentina's commitment to submit the PCT to Congress. With parliamentary support, the ruling party advanced in that bilateral agenda and unlocked a discussion on adherence that had been dragging on for almost three decades.

The commercial relationship between the United States and Argentina is advancing.
The commercial relationship between the United States and Argentina is advancing.

The PCT is a multilateral treaty administered by the World Intellectual Property Organization (WIPO), whose system includes 159 countries. Its mechanism allows for patent protection for an invention in different markets through a single international application. For companies, researchers, and entrepreneurs, this simplifies the initial filing and facilitates the planning of procedures abroad.

During the debate, the ruling party described the instance as "a historic moment". A small or medium-sized enterprise from the provinces, researchers from Conicet, or an emerging tech company could benefit from the system to process the protection of their developments. The Government emphasized the possibility of reducing crippling costs by facilitating access to the international mechanism.

The Government obtained its approval in the Senate.
The Government obtained its approval in the Senate.

The Kirchnerism criticized the initiative through the Formosan José Mayans, who claimed that the Kirchnerists were "horrified" and argued that adherence would harm the Argentine generic drug industry. Their "objections" did not prevent the ruling party from gathering the necessary votes to approve the historic initiative.

The granting of each patent will continue to be the responsibility of the competent national or regional offices, which will evaluate applications according to their regulations. The international mechanism organizes and simplifies the processing, while retaining the decision of patenting in each jurisdiction. In political terms, the sanction adds a concrete result to the agenda of rapprochement between Milei and Trump and paves the way for Argentina's incorporation into the system.